The global tubeless insulin pump market size was US$ 1,066 million in 2021. The global tubeless insulin pump market size is forecast to reach US$ 6,027 million by 2030, growing at a compound annual growth rate (CAGR) of 21.7% during the forecast period from 2022 to 2030.
Insulin patch pumps are another name for tubeless insulin pumps, which are small, discrete, and lightweight. These products are unobtrusive, economical, easily cling to human skin, and simple to use. Patients with type 1 diabetes prefer tubeless insulin pumps, according to NCBI. These pumps now use a bladder, spring, step motor, piezoelectric crystal, manual pumping chamber, and nitinol wire to deliver insulin. There are many different sizes and technological options for these tubeless insulin pumps. These items can be used and worn well beneath garments.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. By directly affecting the industry, disturbing the market and supply chain, and distorting financial markets, the pandemic has had an effect on the world economy. COVID-19 affected the medical device market by slowing the uptake of new products. In numerous nations, national emergencies were put into effect to stop the virus's spread. The closure and restrictions on movement had a significant impact on medical practices, especially those for managing diabetes.
Regional Analysis
North America garnered the major market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the improvements in diabetic management solutions and rising diabetes cases. Additionally, a number of regional government initiatives and informational meetings have encouraged regional tubeless insulin pump market enterprises to launch efficient and cutting-edge diabetes management and treatment tools. The region's need for pumps will be driven by higher device penetration, expanding advancements, a preference for enhanced home care settings, and an expansion in the number of manufacturers and suppliers.
Leading Competitors
The leading prominent companies profiled in the global tubeless insulin pump market are:
Scope of the Report
The global tubeless insulin pump market segmentation focuses on Component, End-Use, and Region.
Segmentation based on Component
Segmentation based on End-Use
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL TUBELESS INSULIN PUMP MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL TUBELESS INSULIN PUMP MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL TUBELESS INSULIN PUMP MARKET, BY COMPONENT
5.1 OVERVIEW
5.2 POD/PATCH
5.3 REMOTE
5.4 OTHERS
6 GLOBAL TUBELESS INSULIN PUMP MARKET, BY END-USE
6.1 OVERVIEW
6.2 HOME CARE
6.3 HOSPITALS & CLINICS
6.4 OTHERS
7 GLOBAL TUBELESS INSULIN PUMP MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL TUBELESS INSULIN PUMP MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILES
9.1 INSULET CORPORATION
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.2 JOHNSON AND JOHNSON
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.3 MEDTRUM TECHNOLOGIES INCORPORATED
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.4 ROCHE HOLDING AG
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.5 CELLNOVO GROUP SA
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.6 SPRING HEALTH SOLUTION LIMITED
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.7 DEBIOTECH, CEQUR SA
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.8 ABBOTT DIABETES CARE
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.9 MEDTRONIC PLC.
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.10 TANDEM DIABETES CARE
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved